These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7748691

  • 1. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
    Lim YJ, Yong AB, Warne GL, Montalto J.
    J Paediatr Child Health; 1995 Feb; 31(1):47-50. PubMed ID: 7748691
    [Abstract] [Full Text] [Related]

  • 2. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Shibata Y.
    Nihon Naibunpi Gakkai Zasshi; 1991 Aug 20; 67(8):819-39. PubMed ID: 1813324
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two different radioimmunoassays to measure 17-hydroxyprogesterone during treatment monitoring of children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kamrath C, Böhles H, Maser-Gluth C.
    Clin Chim Acta; 2011 Jan 14; 412(1-2):186-9. PubMed ID: 20933513
    [Abstract] [Full Text] [Related]

  • 4. [Reevaluation of recalled infants by neonatal mass screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Diagnostic value of pregnanetriolone in a single urine specimen using glass capillary gas chromatography].
    Hikita Y.
    Nihon Naibunpi Gakkai Zasshi; 1985 Mar 20; 61(3):197-219. PubMed ID: 3874793
    [Abstract] [Full Text] [Related]

  • 5. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. I. Microfilter paper methods for radioimmunoassay of 17 alpha-hydroxyprogesterone].
    Shimozawa K.
    Nihon Naibunpi Gakkai Zasshi; 1983 Dec 20; 59(12):1845-9. PubMed ID: 6609091
    [Abstract] [Full Text] [Related]

  • 6. Correlation of blood-spot 17-hydroxyprogesterone daily profiles and urinary steroid profiles in congenital adrenal hyperplasia.
    Erhardt E, Sólyom J, Homoki J, Juricskay S, Soltész G.
    J Pediatr Endocrinol Metab; 2000 Feb 20; 13(2):205-10. PubMed ID: 10711668
    [Abstract] [Full Text] [Related]

  • 7. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency.
    Zerah M, Pang SY, New MI.
    J Clin Endocrinol Metab; 1987 Aug 20; 65(2):227-32. PubMed ID: 3496350
    [Abstract] [Full Text] [Related]

  • 8. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
    Sólyom J.
    Clin Endocrinol (Oxf); 1981 Jun 20; 14(6):547-53. PubMed ID: 7296904
    [Abstract] [Full Text] [Related]

  • 9. Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children.
    Ghizzoni L, Bernasconi S, Virdis R, Vottero A, Ziveri M, Volta C, Iughetti L, Giovannelli G.
    Metabolism; 1994 Mar 20; 43(3):372-7. PubMed ID: 8139487
    [Abstract] [Full Text] [Related]

  • 10. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 11. Reversed-phase high-performance liquid chromatography separation of adrenal steroids prior to radioimmunoassay: application in congenital adrenal hyperplasia.
    Fernandes VT, Ribeiro-Neto LM, Lima SB, Vieira JG, Verreschi IT, Kater CE.
    J Chromatogr Sci; 2003 Dec 09; 41(5):251-4. PubMed ID: 12841953
    [Abstract] [Full Text] [Related]

  • 12. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ, Wellen JJ, Rijken JC, Stoelinga GB, Benraad TJ.
    J Clin Endocrinol Metab; 1983 Dec 09; 57(6):1150-4. PubMed ID: 6605355
    [Abstract] [Full Text] [Related]

  • 13. 17-Hydroxyprogesterone in normal children and congenital adrenal hyperplasia. Measurement in serum by radioimmunoassay after thin-layer chromatography.
    Petersen KE, Christensen T.
    Acta Paediatr Scand; 1979 Mar 09; 68(2):205-11. PubMed ID: 217232
    [Abstract] [Full Text] [Related]

  • 14. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 3. An enzyme-linked immunosorbent assay for dried blood 17 alpha-hydroxyprogesterone].
    Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N.
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb 20; 63(2):113-22. PubMed ID: 3494638
    [Abstract] [Full Text] [Related]

  • 15. Home monitoring of 17 alpha-hydroxyprogesterone levels by filter paper blood spots in patients with 21-hydroxylase deficiency.
    Shimon I, Kaiserman I, Sack J.
    Horm Res; 1995 Feb 20; 44(6):247-52. PubMed ID: 8808009
    [Abstract] [Full Text] [Related]

  • 16. Detection of late onset steroid 21-hydroxylase deficiency by capillary gas chromatographic profiling of urinary steroids in children and adolescents.
    Homoki J, Solyom J, Teller WM.
    Eur J Pediatr; 1988 Apr 20; 147(3):257-62. PubMed ID: 3260557
    [Abstract] [Full Text] [Related]

  • 17. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
    Dubinski I, Bechtold Dalla-Pozza S, Bidlingmaier M, Reisch N, Schmidt H.
    J Pediatr Endocrinol Metab; 2021 Dec 20; 34(12):1543-1548. PubMed ID: 34523293
    [Abstract] [Full Text] [Related]

  • 18. First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency.
    Itonaga T, Izawa M, Hamajima T, Hasegawa Y.
    Front Endocrinol (Lausanne); 2021 Dec 20; 12():808254. PubMed ID: 35140686
    [Abstract] [Full Text] [Related]

  • 19. Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia.
    Birkebaek NH, Hougaard DM, Cohen AS.
    J Pediatr Endocrinol Metab; 2017 Jan 01; 30(1):85-88. PubMed ID: 27977405
    [Abstract] [Full Text] [Related]

  • 20. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations.
    Golden MP, Lippe BM, Kaplan SA, Lavin N, Slavin J.
    Pediatrics; 1978 Jun 01; 61(6):867-71. PubMed ID: 149950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.